Home / Inspections / 1196111

FDA Inspection 1196111 — Bayer Healthcare Pharmaceuticals Inc.

Bayer Healthcare Pharmaceuticals Inc. — FEI 2243252

The FDA completed an inspection of Bayer Healthcare Pharmaceuticals Inc. on February 8, 2023 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 8, 2023
Fiscal Year
2023
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Whippany, NJ (United States)

Additional Details

FSVP

Facility

Other inspections at this facility

  • 1286004 (NAI Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1277153 (NAI Fri Aug 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1251837 (NAI Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1153395 (NAI Wed Sep 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067092 (NAI Thu Aug 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources